Evidence map›Paper›PMID 37175206›Full record

ArticleMolecules (Basel, Switzerland)2023

Enhancing Efficiency of Natural Product Structure Revision: Leveraging CASE and DFT over Total Synthesis.

Mikhail Elyashberg, Sriram Tyagarajan, Mihir Mandal, Alexei V Buevich

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mikhail ElyashbergAdvanced Chemistry Development Inc. (ACD/Labs), Toronto, ON M5C 1B5, Canada.ORCID 0000-0001-9736-2427
Sriram TyagarajanMedicinal Chemistry, Merck & Co., Inc., Kenilworth, NJ 07033, USA.ORCID 0000-0002-1123-7199
Mihir MandalMedicinal Chemistry, Merck & Co., Inc., Kenilworth, NJ 07033, USA.
Alexei V BuevichAnalytical Research and Development, Merck & Co., Inc., Kenilworth, NJ 07033, USA.ORCID 0000-0002-5968-9151

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products remain one of the major sources of coveted, biologically active compounds. Each isolated compound undergoes biological testing, and its structure is usually established using a set of spectroscopic techniques (NMR, MS, UV-IR, ECD, VCD, etc.). However, the number of erroneously determined structures remains noticeable. Structure revisions are very costly, as they usually require extensive use of spectroscopic data, computational chemistry, and total synthesis. The cost is particularly high when a biologically active compound is resynthesized and the product is inactive because its structure is wrong and remains unknown. In this paper, we propose using Computer-Assisted Structure Elucidation (CASE) and Density Functional Theory (DFT) methods as tools for preventive verification of the originally proposed structure, and elucidation of the correct structure if the original structure is deemed to be incorrect. We examined twelve real cases in which structure revisions of natural products were performed using total synthesis, and we showed that in each of these cases, time-consuming total synthesis could have been avoided if CASE and DFT had been applied. In all described cases, the correct structures were established within minutes of using the originally published NMR and MS data, which were sometimes incomplete or had typos.

Indexed as

CASEDFTnatural productsNMRstructure revision

Identifiers

PMID37175206
PMCPMC10180399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.